Journal article
Authors list: Hardt, PD; Mazurek, S; Toepler, M; Schlierbach, P; Bretzel, RG; Eigenbrodt, E; Kloer, HU
Publication year: 2004
Pages: 980-984
Journal: British Journal of Cancer
Volume number: 91
Issue number: 5
ISSN: 0007-0920
Open access status: Hybrid
DOI Link: https://doi.org/10.1038/sj.bjc.6602033
Publisher: Springer Nature [academic journals on nature.com]
Abstract:
Proliferating cells, especially tumour cells, express a special isoenzyme of pyruvate kinase, termed M2-PK, which can occur in a tetrameric form with a high affinity to its substrate, phosphoenolpyruvate (PEP), and in a dimeric form with a low PEP affinity. In tumour cells, the dimeric form is usually predominant and is therefore termed Tumour M2-PK. The levels of Tumour M2-PK within tumours and in EDTA-plasma correlate with staging and the ability of the tumour cells to metastasise. Since most colorectal tumours grow intraluminally, it appeared interesting to determine whether Tumour M2-PK is detectable in the faeces of tumour patients. Stool samples were tested by ELISA from controls without colorectal cancer and colorectal cancer patients. Whereas Tumour M2-PK levels were low in the control group (mean value+/-s.e.m.: 3.3+/-0.4, n=144), they were high in the case of colorectal cancer (56.1+/-15.3, n=60). At a cutoff value of 4 U ml(-1), the sensitivity was 73%. TNM and Dukes' classification of the tumours revealed a strong correlation between faecal Tumour M2-PK levels and staging. The determination of Tumour M2-PK in faeces provides a new promising screening tool for colorectal tumours.
Citation Styles
Harvard Citation style: Hardt, P., Mazurek, S., Toepler, M., Schlierbach, P., Bretzel, R., Eigenbrodt, E., et al. (2004) Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer, British Journal of Cancer, 91(5), pp. 980-984. https://doi.org/10.1038/sj.bjc.6602033
APA Citation style: Hardt, P., Mazurek, S., Toepler, M., Schlierbach, P., Bretzel, R., Eigenbrodt, E., & Kloer, H. (2004). Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. British Journal of Cancer. 91(5), 980-984. https://doi.org/10.1038/sj.bjc.6602033
Keywords
GASTROINTESTINAL-CANCER; LUNG-CANCER; M2-PYRUVATE KINASE; MARKER; OCCULT-BLOOD; stool; STOOL; TU M2-PK; tumour M2-PK; tumour screening